United Therapeutics Corporation has entered into an Accelerated Share Repurchase (ASR) agreement with Citibank, N.A. to repurchase approximately $477.6 million of its common stock. This transaction is part of the company's previously announced $2.0 billion share repurchase program.
Key Details
- Agreement Value: Approximately $477.6 million.
- Initial Terms: The company will make an upfront payment of $477.6 million on or around September 10, 2026, and will receive an initial delivery of approximately 719,376 shares, representing about 75% of the expected total.
- Timeline & Settlement: The final number of repurchased shares will be based on the volume-weighted average price during the ASR term. Final settlement is expected to be completed in the fourth quarter of 2026.